- 5 February 2010
New gene responsible for two types of adult-onset muscular dystrophy identified Research part-funded by the Muscular Dystrophy Campaign has led to the identification of a gene which causes limb girdle muscular dystrophy type 2L and Miyoshi myopathy type MMD3. - 26 January 2010
Researchers identify new mutation in myotonic dystrophy type 1 Research funded by the Muscular Dystrophy Campaign has discovered a new type of mutation that affects the severity and inheritance of myotonic dystrophy type 1. - 20 January 2010
Clinical trial initiated to test ataluren (PTC124) in older Duchenne patients A trial has been initiated to test ataluren (PTC124) in Duchenne patients with a nonsense gene mutation who are no longer walking. - 15 January 2010
Start of the utrophin clinical trial for Duchenne muscular dystrophy announced The start of the clinical trial of a drug called ‘BMN 195’ which has the potential to increase the amount of the protein utrophin in boys with Duchenne muscular dystrophy has been announced. - 14 January 2010
New gene causing a type of periodic paralysis discovered Scientists in the US have discovered a gene responsible for a muscle disease called thyrotoxic hypokalemic periodic paralysis. - 7 January 2010
Research could predict age of onset of heart problems in Becker muscular dystrophy Analysing the DNA of individuals with Becker muscular dystrophy could be used to predict when they will begin to develop heart problems, researchers report. - 5 January 2010
UK exon skipping clinical trial for Duchenne reports promising preliminary results AVI BioPharma has announced some promising initial results midway through the UK body wide (systemic) exon skipping clinical trial for Duchenne muscular dystrophy. - 21 December 2009
New drug for spinal muscular atrophy shows early promise Researchers have discovered a drug that extends the lifespan of a mouse model of spinal muscular atrophy if administered to the mice shortly after birth. - 11 December 2009
World’s leading Duchenne experts agree comprehensive treatment guidelines Comprehensive guidelines to improve the multidisciplinary care of individuals with Duchenne muscular dystrophy have been published after consulting 84 of the world’s leading Duchenne muscular dystrophy experts. - 10 December 2009
New Target Research magazine published! The second issue of Target Research- our magazine dedicated to research news and issues- has been published and is now available to download.
